Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis

Galangin has activity modulating cell cycle arrest on luminal cancer cells and has high selectivity and low cytotoxicity for normal cells. This research intends to know galangin's prospective targets for promoting cell cycle arrest in luminal breast cancer via experimental in vitro, network ph...

Full description

Saved in:
Bibliographic Details
Main Authors: Diyah Novi Sekarini, Yohanes Surya Jati, Nur Ayunie Zulkepli, Dyaningtyas Dewi Pamungkas Putri
Format: Article
Language:English
Published: Bogor Agricultural University 2025-03-01
Series:Hayati Journal of Biosciences
Online Access:https://journal.ipb.ac.id/index.php/hayati/article/view/59628
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849725285204754432
author Diyah Novi Sekarini
Yohanes Surya Jati
Nur Ayunie Zulkepli
Dyaningtyas Dewi Pamungkas Putri
author_facet Diyah Novi Sekarini
Yohanes Surya Jati
Nur Ayunie Zulkepli
Dyaningtyas Dewi Pamungkas Putri
author_sort Diyah Novi Sekarini
collection DOAJ
description Galangin has activity modulating cell cycle arrest on luminal cancer cells and has high selectivity and low cytotoxicity for normal cells. This research intends to know galangin's prospective targets for promoting cell cycle arrest in luminal breast cancer via experimental in vitro, network pharmacology, and bioinformatics validation. In this research, MCF-7, a luminal model cell, was treated with galangin dose-dependent. Consequently, galangin exhibited a cytotoxic impact, with IC50 values of 117.86 μM. After that, SwissTargetPrediction, UALCAN, ShinyGO, and OncoLnc were used for bioinformatics validations, and Cytoscape software and the STRING website were used for computational analysis. Eight overlapping galangin target genes against luminal breast cancer were found. According to the analysis of the protein-protein interaction (PPI) network, eight hub genes-including CDK1, PLK1, TOP2A, ESR1, AURKB, NEK2, MMP9, and CA12-had the highest degree of freedom. Cell cycle regulation has been discovered to be tightly associated with overexpression of CDK1, PLK1, AURKB, and NEK2. By influencing the cell cycle, galangin inhibits the growth of luminal breast cancer, as determined by GO and KEGG enrichment analyses. In conclusion, by triggering cell cycle arrest, galangin may be used as a prospective chemotherapeutic treatment.
format Article
id doaj-art-7a300f1820a447538b6870eaaa540cdd
institution DOAJ
issn 1978-3019
2086-4094
language English
publishDate 2025-03-01
publisher Bogor Agricultural University
record_format Article
series Hayati Journal of Biosciences
spelling doaj-art-7a300f1820a447538b6870eaaa540cdd2025-08-20T03:10:31ZengBogor Agricultural UniversityHayati Journal of Biosciences1978-30192086-40942025-03-0132410.4308/hjb.32.4.969-979Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics AnalysisDiyah Novi Sekarini0Yohanes Surya Jati1Nur Ayunie Zulkepli2Dyaningtyas Dewi Pamungkas Putri3Department of Biotechnology, Graduate School, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia. Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaDepartment of Biotechnology, Graduate School, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia. Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, IndonesiaCentre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA, Selangor Branch, Puncak Alam Campus, Selangor Malaysia. Atta-ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARA, Selangor Branch, Puncak Alam Campus, Selangor MalaysiaCancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia. Pharmacology and Toxicology Laboratory, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia. Laboratory of Advanced Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia Galangin has activity modulating cell cycle arrest on luminal cancer cells and has high selectivity and low cytotoxicity for normal cells. This research intends to know galangin's prospective targets for promoting cell cycle arrest in luminal breast cancer via experimental in vitro, network pharmacology, and bioinformatics validation. In this research, MCF-7, a luminal model cell, was treated with galangin dose-dependent. Consequently, galangin exhibited a cytotoxic impact, with IC50 values of 117.86 μM. After that, SwissTargetPrediction, UALCAN, ShinyGO, and OncoLnc were used for bioinformatics validations, and Cytoscape software and the STRING website were used for computational analysis. Eight overlapping galangin target genes against luminal breast cancer were found. According to the analysis of the protein-protein interaction (PPI) network, eight hub genes-including CDK1, PLK1, TOP2A, ESR1, AURKB, NEK2, MMP9, and CA12-had the highest degree of freedom. Cell cycle regulation has been discovered to be tightly associated with overexpression of CDK1, PLK1, AURKB, and NEK2. By influencing the cell cycle, galangin inhibits the growth of luminal breast cancer, as determined by GO and KEGG enrichment analyses. In conclusion, by triggering cell cycle arrest, galangin may be used as a prospective chemotherapeutic treatment. https://journal.ipb.ac.id/index.php/hayati/article/view/59628
spellingShingle Diyah Novi Sekarini
Yohanes Surya Jati
Nur Ayunie Zulkepli
Dyaningtyas Dewi Pamungkas Putri
Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis
Hayati Journal of Biosciences
title Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis
title_full Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis
title_fullStr Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis
title_full_unstemmed Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis
title_short Cell Cycle Target Protein Induced by Galangin Treatment in Luminal Cells Confirmed by Bioinformatics Analysis
title_sort cell cycle target protein induced by galangin treatment in luminal cells confirmed by bioinformatics analysis
url https://journal.ipb.ac.id/index.php/hayati/article/view/59628
work_keys_str_mv AT diyahnovisekarini cellcycletargetproteininducedbygalangintreatmentinluminalcellsconfirmedbybioinformaticsanalysis
AT yohanessuryajati cellcycletargetproteininducedbygalangintreatmentinluminalcellsconfirmedbybioinformaticsanalysis
AT nurayuniezulkepli cellcycletargetproteininducedbygalangintreatmentinluminalcellsconfirmedbybioinformaticsanalysis
AT dyaningtyasdewipamungkasputri cellcycletargetproteininducedbygalangintreatmentinluminalcellsconfirmedbybioinformaticsanalysis